PKM and chronic myelogenous leukemia, BCR-ABL1 positive: Our study demonstrated the synergistic effect of Chi and IM on IM-sensitive and IM-resistant CML cells by activating the PPARγ and mTOR pathway, weakening the PKM2 and STAT5.